Hangzhou TianMuShan Pharmaceutical Enterprise Co (SHSE:600671) EV-to-Revenue : 7.62 (As of Dec. 15, 2024)

Hangzhou TianMuShan Pharmaceutical Enterprise Co EV-to-Revenue Chart

Hangzhou TianMuShan Pharmaceutical Enterprise Co Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
EV-to-Revenue		Get a 7-Day Free Trial					5.37	5.73	8.18	11.49	11.95

Hangzhou TianMuShan Pharmaceutical Enterprise Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EV-to-Revenue	Get a 7-Day Free Trial															10.37	11.95	9.10	7.18	6.14

Competitive Comparison of Hangzhou TianMuShan Pharmaceutical Enterprise Co's EV-to-Revenue

For the Drug Manufacturers - General subindustry, Hangzhou TianMuShan Pharmaceutical Enterprise Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hangzhou TianMuShan Pharmaceutical Enterprise Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hangzhou TianMuShan Pharmaceutical Enterprise Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Hangzhou TianMuShan Pharmaceutical Enterprise Co's EV-to-Revenue falls into.

Hangzhou TianMuShan Pharmaceutical Enterprise Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Hangzhou TianMuShan Pharmaceutical Enterprise Co's EV-to-Revenue for today is calculated as:

Hangzhou TianMuShan Pharmaceutical Enterprise Co's current Enterprise Value is ¥1,221.5 Mil.
Hangzhou TianMuShan Pharmaceutical Enterprise Co's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥160.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hangzhou TianMuShan Pharmaceutical Enterprise Co  (SHSE:600671) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Hangzhou TianMuShan Pharmaceutical Enterprise Co's PS Ratiofor today is calculated as:

Hangzhou TianMuShan Pharmaceutical Enterprise Co's share price for today is ¥9.36.
Hangzhou TianMuShan Pharmaceutical Enterprise Co's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.32.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hangzhou TianMuShan Pharmaceutical Enterprise Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Hangzhou TianMuShan Pharmaceutical Enterprise Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Hangzhou TianMuShan Pharmaceutical Enterprise Co Business Description